Okvau continues to impress.Further drill results are expectedThis is shaping up to be a decent purchase by the team at Renaissance - interest this morning reflects the resultsMarchello
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago